Review



pkc ζ  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Cell Signaling Technology Inc pkc ζ
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Pkc ζ, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 58 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pmc12973334-89-15-17?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 58 article reviews
    pkc ζ - by Bioz Stars, 2026-07
    94/100 stars

    Images

    1) Product Images from "IL ‐ 17A Promotes NETs Formation via the PKCζ – ERK – ROS – PAD4 Pathway in a Mouse Model of Ischemic Stroke"

    Article Title: IL ‐ 17A Promotes NETs Formation via the PKCζ – ERK – ROS – PAD4 Pathway in a Mouse Model of Ischemic Stroke

    Journal: CNS Neuroscience & Therapeutics

    doi: 10.1002/cns.70825

    IL‐17mAb treatment can reduce the expression of PAD4, MPO, CitH3, PKC‐ζ, and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Figure Legend Snippet: IL‐17mAb treatment can reduce the expression of PAD4, MPO, CitH3, PKC‐ζ, and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.

    Techniques Used: Expressing, Control, Western Blot, Comparison

    IL‐17A regulates the expression of PAD4 through PKCζ‐ERK1/2‐ROS. (A) Flow cytometry images for the sorting and identification of neutrophils using CD11b and Ly‐6G antibodies. (B) Cellular immunofluorescence of Ly‐6G showed the purity of neutrophils. (C) Primary neutrophils were taken and Western blot was used to detect the expression of target proteins under different group stimulation conditions. rm‐IL‐17A, recombinant mouse IL‐17A; ζ‐Stat, inhibitor of PKC‐ζ; Ravoxertinib, ERK kinase inhibitor; Apocynin, NADPH oxidase inhibitor; GSK484, PAD4 inhibitor. (D) Statistical graph of PCK‐ζ. (E) Statistical graph of ERK phosphorylation level. (F) Statistical graph of PAD4 expression. (G and H) The levels of ROS were detected by DCFH‐DA probe in primary neutrophils cells under different group stimulation. The statistical graph (G) and the representative flow cytometry graph (H) were presented. Statistical results were analyzed by One‐way ANOVA. Bonferroni test was used for comparison between groups, *** p < 0.001, ### p < 0.001, ## p < 0.01, # p < 0.05, n = 6 per group.
    Figure Legend Snippet: IL‐17A regulates the expression of PAD4 through PKCζ‐ERK1/2‐ROS. (A) Flow cytometry images for the sorting and identification of neutrophils using CD11b and Ly‐6G antibodies. (B) Cellular immunofluorescence of Ly‐6G showed the purity of neutrophils. (C) Primary neutrophils were taken and Western blot was used to detect the expression of target proteins under different group stimulation conditions. rm‐IL‐17A, recombinant mouse IL‐17A; ζ‐Stat, inhibitor of PKC‐ζ; Ravoxertinib, ERK kinase inhibitor; Apocynin, NADPH oxidase inhibitor; GSK484, PAD4 inhibitor. (D) Statistical graph of PCK‐ζ. (E) Statistical graph of ERK phosphorylation level. (F) Statistical graph of PAD4 expression. (G and H) The levels of ROS were detected by DCFH‐DA probe in primary neutrophils cells under different group stimulation. The statistical graph (G) and the representative flow cytometry graph (H) were presented. Statistical results were analyzed by One‐way ANOVA. Bonferroni test was used for comparison between groups, *** p < 0.001, ### p < 0.001, ## p < 0.01, # p < 0.05, n = 6 per group.

    Techniques Used: Expressing, Flow Cytometry, Immunofluorescence, Western Blot, Recombinant, Phospho-proteomics, Comparison



    Similar Products

    94
    Santa Cruz Biotechnology pkmζ
    Knockdown of KIBRA in contralateral ACC prevents the upregulation of KIBRA, <t>p</t> <t>-PKMζ/GluR1</t> signaling pathways, and neuroinflammation in CPTP rats. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, TNF-α, and IL-1β levels in ACC analyzed 21 days after the sham operation, thoracotomy, or KIBRA − + thoracotomy. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼8 rats in each group. ACC, anterior cingulate gyrus; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.
    Pkmζ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pmc12994516-91-45-47?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    pkmζ - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology p pkmζ
    The KIBRA and p <t>-PKMζ</t> are activated in contralateral ACC neurons after CPTP. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, and PKMζ levels in contralateral ACC at different time points in Thoracotomy pain (A-C) or Thoracotomy no pain (D-F), * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 vs Sham group; the data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼7 rats in each group. (G-H) The photographs of the double immunofluorescence staining show that KIBRA and p -PKMζ are only colocalized with neuron markers (NeuN) but not with astrocyte marker (GFAP) and microglia marker (Iba1) in the Sham and CPTP groups. The white arrowheads indicate the co-immunostaining. Scale bar, 100 μm. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; KIBRA, kidney and brain-expressed protein; NeuN, neuron-specific nuclear protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ.
    P Pkmζ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pmc12994516-91-39-47?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    p pkmζ - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology jan
    The KIBRA and p <t>-PKMζ</t> are activated in contralateral ACC neurons after CPTP. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, and PKMζ levels in contralateral ACC at different time points in Thoracotomy pain (A-C) or Thoracotomy no pain (D-F), * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 vs Sham group; the data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼7 rats in each group. (G-H) The photographs of the double immunofluorescence staining show that KIBRA and p -PKMζ are only colocalized with neuron markers (NeuN) but not with astrocyte marker (GFAP) and microglia marker (Iba1) in the Sham and CPTP groups. The white arrowheads indicate the co-immunostaining. Scale bar, 100 μm. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; KIBRA, kidney and brain-expressed protein; NeuN, neuron-specific nuclear protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ.
    Jan, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pm41886453-873-0-6?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    jan - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc pkc ζ
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Pkc ζ, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pmc12973334-89-15-17?v=Cell+Signaling+Technology+Inc
    Average 94 stars, based on 1 article reviews
    pkc ζ - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti pkcζ antibody
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Anti Pkcζ Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pmc12914311-28-0-3?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    anti pkcζ antibody - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology mouse anti pkcζ
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Mouse Anti Pkcζ, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/bio_rxiv__64898__2026__01__30__702717-349-44-47?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    mouse anti pkcζ - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti pkc ζ h1
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Anti Pkc ζ H1, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pm41455491-74-11-13?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    anti pkc ζ h1 - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    94
    Santa Cruz Biotechnology anti apkc h1 mouse
    IL‐17mAb treatment can reduce the expression of <t>PAD4,</t> <t>MPO,</t> CitH3, <t>PKC‐ζ,</t> and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.
    Anti Apkc H1 Mouse, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pkc+%CE%B6/pm41419573-293-34-38?v=Santa+Cruz+Biotechnology
    Average 94 stars, based on 1 article reviews
    anti apkc h1 mouse - by Bioz Stars, 2026-07
    94/100 stars
      Buy from Supplier

    Image Search Results


    Knockdown of KIBRA in contralateral ACC prevents the upregulation of KIBRA, p -PKMζ/GluR1 signaling pathways, and neuroinflammation in CPTP rats. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, TNF-α, and IL-1β levels in ACC analyzed 21 days after the sham operation, thoracotomy, or KIBRA − + thoracotomy. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼8 rats in each group. ACC, anterior cingulate gyrus; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: Knockdown of KIBRA in contralateral ACC prevents the upregulation of KIBRA, p -PKMζ/GluR1 signaling pathways, and neuroinflammation in CPTP rats. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, TNF-α, and IL-1β levels in ACC analyzed 21 days after the sham operation, thoracotomy, or KIBRA − + thoracotomy. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼8 rats in each group. ACC, anterior cingulate gyrus; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Knockdown, Protein-Protein interactions

    Overexpression of KIBRA in ACC causes allodynia and activates p -PKMζ/GluR1 signaling pathways and neuroinflammation. (A) Experiment designs are shown. (B) Mechanical hyperalgesia ratio on 7, 14, and 21 days after thoracotomy or KIBRA overexpression. **** P < 0.0001 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points for pain rats after injection of rAAV-CMV-wwc1-3xFLAG-WPREs or thoracotomy, * P < 0.05, *** P < 0.001, and **** P < 0.0001 vs Sham group, &&&& P < 0.00001 vs KIBRA + pain group, the data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 12 in KIBRA + pain, n = 8 in KIBRA + no pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed 21 days in Sham, KIBRA + pain, and KIBRA + no pain rats. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4 in each group. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: Overexpression of KIBRA in ACC causes allodynia and activates p -PKMζ/GluR1 signaling pathways and neuroinflammation. (A) Experiment designs are shown. (B) Mechanical hyperalgesia ratio on 7, 14, and 21 days after thoracotomy or KIBRA overexpression. **** P < 0.0001 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points for pain rats after injection of rAAV-CMV-wwc1-3xFLAG-WPREs or thoracotomy, * P < 0.05, *** P < 0.001, and **** P < 0.0001 vs Sham group, &&&& P < 0.00001 vs KIBRA + pain group, the data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 12 in KIBRA + pain, n = 8 in KIBRA + no pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed 21 days in Sham, KIBRA + pain, and KIBRA + no pain rats. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4 in each group. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Over Expression, Protein-Protein interactions, Injection

    ACC overexpression KIBRA combined with thoracotomy induced CPTP in all rats. (A) Experiment designs are shown. (B) Incidence of pain on 7, 14, and 21 days after thoracotomy in KIBRA overexpression rats. ** P < 0.01 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points in KIBRA + no pain + Thoracotomy pain, Thoracotomy pain, or Sham group, **** P < 0.0001 vs Sham group, & P < 0.05 vs Thoracotomy pain group. The data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 14 in KIBRA + no pain + Thoracotomy pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed on POD21 in Sham, Thoracotomy pain, or KIBRA + no pain + Thoracotomy pain rats, n = 4 rats in each group. The data were analyzed by 1-way ANOVA followed by Tukey post hoc test. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: ACC overexpression KIBRA combined with thoracotomy induced CPTP in all rats. (A) Experiment designs are shown. (B) Incidence of pain on 7, 14, and 21 days after thoracotomy in KIBRA overexpression rats. ** P < 0.01 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points in KIBRA + no pain + Thoracotomy pain, Thoracotomy pain, or Sham group, **** P < 0.0001 vs Sham group, & P < 0.05 vs Thoracotomy pain group. The data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 14 in KIBRA + no pain + Thoracotomy pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed on POD21 in Sham, Thoracotomy pain, or KIBRA + no pain + Thoracotomy pain rats, n = 4 rats in each group. The data were analyzed by 1-way ANOVA followed by Tukey post hoc test. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Over Expression

    The KIBRA and p -PKMζ are activated in contralateral ACC neurons after CPTP. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, and PKMζ levels in contralateral ACC at different time points in Thoracotomy pain (A-C) or Thoracotomy no pain (D-F), * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 vs Sham group; the data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼7 rats in each group. (G-H) The photographs of the double immunofluorescence staining show that KIBRA and p -PKMζ are only colocalized with neuron markers (NeuN) but not with astrocyte marker (GFAP) and microglia marker (Iba1) in the Sham and CPTP groups. The white arrowheads indicate the co-immunostaining. Scale bar, 100 μm. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; KIBRA, kidney and brain-expressed protein; NeuN, neuron-specific nuclear protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: The KIBRA and p -PKMζ are activated in contralateral ACC neurons after CPTP. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, and PKMζ levels in contralateral ACC at different time points in Thoracotomy pain (A-C) or Thoracotomy no pain (D-F), * P < 0.05, ** P < 0.01, *** P < 0.001, and **** P < 0.0001 vs Sham group; the data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼7 rats in each group. (G-H) The photographs of the double immunofluorescence staining show that KIBRA and p -PKMζ are only colocalized with neuron markers (NeuN) but not with astrocyte marker (GFAP) and microglia marker (Iba1) in the Sham and CPTP groups. The white arrowheads indicate the co-immunostaining. Scale bar, 100 μm. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GFAP, glial fibrillary acidic protein; Iba1, ionized calcium-binding adapter molecule 1; KIBRA, kidney and brain-expressed protein; NeuN, neuron-specific nuclear protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Double Immunofluorescence Staining, Marker, Immunostaining, Binding Assay

    Knockdown of KIBRA in contralateral ACC prevents the upregulation of KIBRA, p -PKMζ/GluR1 signaling pathways, and neuroinflammation in CPTP rats. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, TNF-α, and IL-1β levels in ACC analyzed 21 days after the sham operation, thoracotomy, or KIBRA − + thoracotomy. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼8 rats in each group. ACC, anterior cingulate gyrus; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: Knockdown of KIBRA in contralateral ACC prevents the upregulation of KIBRA, p -PKMζ/GluR1 signaling pathways, and neuroinflammation in CPTP rats. (A-F) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, TNF-α, and IL-1β levels in ACC analyzed 21 days after the sham operation, thoracotomy, or KIBRA − + thoracotomy. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4∼8 rats in each group. ACC, anterior cingulate gyrus; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Knockdown, Protein-Protein interactions

    Overexpression of KIBRA in ACC causes allodynia and activates p -PKMζ/GluR1 signaling pathways and neuroinflammation. (A) Experiment designs are shown. (B) Mechanical hyperalgesia ratio on 7, 14, and 21 days after thoracotomy or KIBRA overexpression. **** P < 0.0001 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points for pain rats after injection of rAAV-CMV-wwc1-3xFLAG-WPREs or thoracotomy, * P < 0.05, *** P < 0.001, and **** P < 0.0001 vs Sham group, &&&& P < 0.00001 vs KIBRA + pain group, the data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 12 in KIBRA + pain, n = 8 in KIBRA + no pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed 21 days in Sham, KIBRA + pain, and KIBRA + no pain rats. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4 in each group. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: Overexpression of KIBRA in ACC causes allodynia and activates p -PKMζ/GluR1 signaling pathways and neuroinflammation. (A) Experiment designs are shown. (B) Mechanical hyperalgesia ratio on 7, 14, and 21 days after thoracotomy or KIBRA overexpression. **** P < 0.0001 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points for pain rats after injection of rAAV-CMV-wwc1-3xFLAG-WPREs or thoracotomy, * P < 0.05, *** P < 0.001, and **** P < 0.0001 vs Sham group, &&&& P < 0.00001 vs KIBRA + pain group, the data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 12 in KIBRA + pain, n = 8 in KIBRA + no pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed 21 days in Sham, KIBRA + pain, and KIBRA + no pain rats. The data were analyzed by 1-way ANOVA followed by Tukey multiple comparisons test, n = 4 in each group. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Over Expression, Protein-Protein interactions, Injection

    ACC overexpression KIBRA combined with thoracotomy induced CPTP in all rats. (A) Experiment designs are shown. (B) Incidence of pain on 7, 14, and 21 days after thoracotomy in KIBRA overexpression rats. ** P < 0.01 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points in KIBRA + no pain + Thoracotomy pain, Thoracotomy pain, or Sham group, **** P < 0.0001 vs Sham group, & P < 0.05 vs Thoracotomy pain group. The data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 14 in KIBRA + no pain + Thoracotomy pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed on POD21 in Sham, Thoracotomy pain, or KIBRA + no pain + Thoracotomy pain rats, n = 4 rats in each group. The data were analyzed by 1-way ANOVA followed by Tukey post hoc test. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Journal: Pain

    Article Title: Kidney and brain-expressed protein upregulation in the anterior cingulate cortex mediates chronic post-thoracotomy pain by the phospho-protein kinase Mζ/glutamate receptor 1 signaling pathway and neuroinflammation in male rats

    doi: 10.1097/j.pain.0000000000003849

    Figure Lengend Snippet: ACC overexpression KIBRA combined with thoracotomy induced CPTP in all rats. (A) Experiment designs are shown. (B) Incidence of pain on 7, 14, and 21 days after thoracotomy in KIBRA overexpression rats. ** P < 0.01 vs Thoracotomy pain group; the data were analyzed by Fisher exact test. (C and D) The threshold% and mechanical pain threshold at different time points in KIBRA + no pain + Thoracotomy pain, Thoracotomy pain, or Sham group, **** P < 0.0001 vs Sham group, & P < 0.05 vs Thoracotomy pain group. The data were analyzed by 2-way ANOVA followed by Tukey multiple comparisons test, n = 8 in Sham, n = 13 in Thoracotomy pain, n = 14 in KIBRA + no pain + Thoracotomy pain group. (E-J) Representative blots and columnar statistical charts show KIBRA, p -PKMζ, PKMζ, GluR1, TNF-α, and IL-1β levels in ACC analyzed on POD21 in Sham, Thoracotomy pain, or KIBRA + no pain + Thoracotomy pain rats, n = 4 rats in each group. The data were analyzed by 1-way ANOVA followed by Tukey post hoc test. ACC, anterior cingulate gyrus; ANOVA, analysis of variance; CPTP, chronic post-thoracotomy pain; GluR1, glutamate receptor 1; IL-1β, interleukin-1β; KIBRA, kidney and brain-expressed protein; PKMζ, protein kinase Mζ; p -PKMζ, phosphorylated protein kinase Mζ; TNF-α, tumor necrosis factor-α.

    Article Snippet: After using the Pierce Bicinchoninic Acid Assay kit to measure the protein concentration, 30 μg protein was separated with SDS-PAGE gels (Bio-Rad, Hercules, CA) and immunoblotted with antibodies against KIBRA (bs-11570R; Bioss, Woburn, MA), GluR1 (67642-1-lg; Proteintech, Rosemont, IL), p -PKMζ (AF3404; Affinity, Cincinnati, OH), PKMζ (sc-17781; Santa Cruz, Dallas, TX), β-actin (EM21002; HUABIO, Hangzhou, China), tumor necrosis factor-α (TNF-α, BS-1857; Bioworld, Dublin, OH), and interleukin-1β (IL-1β, ab9722; Abcam, Cambridge, United Kingdom).

    Techniques: Over Expression

    IL‐17mAb treatment can reduce the expression of PAD4, MPO, CitH3, PKC‐ζ, and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: IL ‐ 17A Promotes NETs Formation via the PKCζ – ERK – ROS – PAD4 Pathway in a Mouse Model of Ischemic Stroke

    doi: 10.1002/cns.70825

    Figure Lengend Snippet: IL‐17mAb treatment can reduce the expression of PAD4, MPO, CitH3, PKC‐ζ, and P‐ERK proteins in mouse brain tissue. The figure shows the expression of PAD4 (A), MPO (B), CitH3 (C), PKC‐ζ (D), and P‐ERK (E) proteins in the brain tissues of mice treated with IL‐17mAb in the 1 h MCAO/R 24 h model. Sham is the sham operation group, control is the operation group, IgG is the isotype control antibody, and the IL‐17mAb group is IL‐17mAb treatment. The left picture is a representative picture of Western blot, and the right picture is a statistical chart. Statistical results were analyzed by One‐way ANOVA. Bonfferoni test was used for comparison between groups. *** p < 0.001 compared with the Sham group, # p < 0.05, ## p < 0.01, ### p < 0.001 compared with MCAO group, + p < 0.05, ++ p < 0.01, +++ p < 0.001compared with the IgG group, n = 6 in each group.

    Article Snippet: PAD4 (#ab96758, Abcam, Cambridge, UK), MPO (#ab208670, Abcam, Cambridge, UK), CitH3 (#ab5103, Abcam, Cambridge, UK), PKC‐ζ (#9368S, CST, Danvers, USA), P‐ERK (#4370S, CST, Danvers, USA), ERK (#4695S, CST, Danvers, USA), and GAPDH (#ab9485, Abcam, Cambridge, UK), followed by incubation with horseradish peroxidase‐conjugated anti‐rabbit, anti‐mouse, and anti‐rat secondary antibodies.

    Techniques: Expressing, Control, Western Blot, Comparison

    IL‐17A regulates the expression of PAD4 through PKCζ‐ERK1/2‐ROS. (A) Flow cytometry images for the sorting and identification of neutrophils using CD11b and Ly‐6G antibodies. (B) Cellular immunofluorescence of Ly‐6G showed the purity of neutrophils. (C) Primary neutrophils were taken and Western blot was used to detect the expression of target proteins under different group stimulation conditions. rm‐IL‐17A, recombinant mouse IL‐17A; ζ‐Stat, inhibitor of PKC‐ζ; Ravoxertinib, ERK kinase inhibitor; Apocynin, NADPH oxidase inhibitor; GSK484, PAD4 inhibitor. (D) Statistical graph of PCK‐ζ. (E) Statistical graph of ERK phosphorylation level. (F) Statistical graph of PAD4 expression. (G and H) The levels of ROS were detected by DCFH‐DA probe in primary neutrophils cells under different group stimulation. The statistical graph (G) and the representative flow cytometry graph (H) were presented. Statistical results were analyzed by One‐way ANOVA. Bonferroni test was used for comparison between groups, *** p < 0.001, ### p < 0.001, ## p < 0.01, # p < 0.05, n = 6 per group.

    Journal: CNS Neuroscience & Therapeutics

    Article Title: IL ‐ 17A Promotes NETs Formation via the PKCζ – ERK – ROS – PAD4 Pathway in a Mouse Model of Ischemic Stroke

    doi: 10.1002/cns.70825

    Figure Lengend Snippet: IL‐17A regulates the expression of PAD4 through PKCζ‐ERK1/2‐ROS. (A) Flow cytometry images for the sorting and identification of neutrophils using CD11b and Ly‐6G antibodies. (B) Cellular immunofluorescence of Ly‐6G showed the purity of neutrophils. (C) Primary neutrophils were taken and Western blot was used to detect the expression of target proteins under different group stimulation conditions. rm‐IL‐17A, recombinant mouse IL‐17A; ζ‐Stat, inhibitor of PKC‐ζ; Ravoxertinib, ERK kinase inhibitor; Apocynin, NADPH oxidase inhibitor; GSK484, PAD4 inhibitor. (D) Statistical graph of PCK‐ζ. (E) Statistical graph of ERK phosphorylation level. (F) Statistical graph of PAD4 expression. (G and H) The levels of ROS were detected by DCFH‐DA probe in primary neutrophils cells under different group stimulation. The statistical graph (G) and the representative flow cytometry graph (H) were presented. Statistical results were analyzed by One‐way ANOVA. Bonferroni test was used for comparison between groups, *** p < 0.001, ### p < 0.001, ## p < 0.01, # p < 0.05, n = 6 per group.

    Article Snippet: PAD4 (#ab96758, Abcam, Cambridge, UK), MPO (#ab208670, Abcam, Cambridge, UK), CitH3 (#ab5103, Abcam, Cambridge, UK), PKC‐ζ (#9368S, CST, Danvers, USA), P‐ERK (#4370S, CST, Danvers, USA), ERK (#4695S, CST, Danvers, USA), and GAPDH (#ab9485, Abcam, Cambridge, UK), followed by incubation with horseradish peroxidase‐conjugated anti‐rabbit, anti‐mouse, and anti‐rat secondary antibodies.

    Techniques: Expressing, Flow Cytometry, Immunofluorescence, Western Blot, Recombinant, Phospho-proteomics, Comparison